Tyra Biosciences, Inc. · NASDAQ:TYRA
Harris Todd received 79,000 Tyra Biosciences, Inc. shares as an award (Form 4)
Traded May 5, 2026 · Filed May 7, 2026
On May 5, 2026, Harris Todd (Director, President and CEO) received 79,000 Tyra Biosciences, Inc. shares as an award, leaving 1,437,631 shares. Filed May 7, 2026 (Form 4).
- Awarded
- 79,000 shares
- Holding after
- 1,437,631 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 5, 2026 | Common Stock | Award | 79,000 | 1,437,631 | Direct |
Source
Related
- Tyra Biosciences, Inc.
- Harris Todd
- Tyra Biosciences, Inc. shareholders
- Form 4 · Harris Todd · Sep 17, 2026
- Schedule 13G · Biotechnology Value Fund L P · Sep 21, 2026
- Form 4 · Rueb Yuliya · Sep 17, 2026
- Form 4 · Fuhrman Alan · Sep 17, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Sep 17, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Sep 17, 2026